In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 17-1349V

Filed: November 13, 2020

UNPUBLISHED

A.W., by her parent and natural 

guardian, AMBER WILSON,

 Petitioner,

v.

SECRETARY OF HEALTH AND 

HUMAN SERVICES,

 Respondent.

Special Master Horner

Attorneys’ Fees and Costs; 

Reasonable Basis; Reasonable 

Expert Costs

Renee J. Gentry, Vaccine Injury Clinic, George Washington Univ. Law School, 

Washington D.C, for petitioners.

Lynn Schlie, U.S. Department of Justice, Washington, DC, for respondent. 

DECISION REGARDING ATTORNEYS’ FEES AND COSTS1

Petitioner initiated this action on September 27, 2017. She alleged that her child, 

A.W., developed type one diabetes mellitus as a result of her October 11, 2014 measles 

mumps rubella (“MMR”) vaccination. She moved to dismiss her claim on August 3, 

2020, and filed a motion to recover attorneys’ fees and costs totaling $32,073.10 on 

September 4, 2020. (ECF No. 51.) Respondent filed his response on September 11, 

2020, and no reply was filed. Accordingly, petitioner’s motion is ripe for resolution. For 

the reasons discussed below, petitioners are awarded attorneys’ fees and costs in the 

reduced amount of $27,273.10.

1 Because this decision contains a reasoned explanation for the special master’s action in this case, it will 

be posted on the United States Court of Federal Claims’ website in accordance with the E-Government 

Act of 2002. See 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic 

Government Services). This means the decision will be available to anyone with access to the 

Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact 

medical or other information the disclosure of which would constitute an unwarranted invasion of privacy. 

If the special master, upon review, agrees that the identified material fits within this definition, it will be 

redacted from public access.
2

Section 15(e)(1) of the Vaccine Act allows the special master to award 

“reasonable attorneys' fees, and other costs.” § 300aa–15(e)(1)(A)–(B). Petitioners are 

entitled to an award of reasonable attorneys' fees and costs if they receive 

compensation under the Vaccine Act, or, even if they are unsuccessful, if the special 

master finds that the petition was filed in good faith and with a reasonable basis. Avera 

v. Sec'y of Health & Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008). In this case, 

respondent confirmed in his response to petitioner’s motion for attorneys’ fees and costs 

that “Respondent is satisfied the statutory requirements for an award of attorneys’ fees 

and costs are met in this case.” (ECF No. 53, p. 2.) This is also consistent with the

determination of reasonable basis in Bhattacharyya, 16-195V, Slip Op (Fed. Cl. Spec. 

Mstr. Nov. 13, 2020), a type one diabetes case relative to a different vaccine filed by the 

same counsel, relying on the same expert, and likewise voluntarily dismissed at about 

the same time.

2

Upon review of petitioner’s motion in this case, the requested hourly rates are in 

accord with what has previously been awarded and I also find the overall hours billed to 

be reasonable. Additionally, all of the costs requested by petitioner are sufficiently 

documented and all of these costs appear reasonable except for petitioner’s expert 

costs. Petitioner requests $9,600.00 for work performed by Mr. Ruscetti from March to 

May of 2019 in preparation of Mr. Ruscetti’s supplemental expert report filed May 28, 

2019. (ECF No. 36; ECF No. 51-1, p. 20.) For reasons I explained in greater detail in 

Bhattacharyya, supra, by mid-2018 reports cowritten by Mr. Ruscetti and his partner, 

Judy Mikovits, had garnered such significant and repeated criticism by special masters 

that it no longer appears to have been reasonable to rely on these experts. I explained 

in Bhattacharyya based on his performance in that case that these criticisms were fairly 

imputed to Mr. Ruscetti’s solo work.

In Bhattacharrya, I declined to compensate any of the costs requested for 

preparation of Mr. Ruscetti’s reports. An additional factor in Bhattacharyya, however, 

was that the costs requested were for a third and fourth report by Mr. Ruscetti, which 

was excessive given the deficiencies in his initial reports. Because that is not a factor in 

this case, I instead reduce Mr. Ruscetti’s fees in this case by 50%. This is consistent 

with the value that other special masters have placed on Mr. Ruscetti’s work. E.g.

Barker v. Sec'y of Health & Human Servs., No. 16-1554V, 2019 WL 4648912, at *6 

(Fed. Cl. Spec. Mstr. Aug. 27, 2019); Bertolucci v. Sec'y of Health & Human Servs., No. 

15-1573, 2019 WL 4256974 (Fed. Cl. Spec. Mstr. Aug. 28, 2019). This results in a 

reduction of $4,800.00. 

In accordance with the Vaccine Act, 42 U.S.C. § 300aa-15(e) (2012), I have 

reviewed the billing records and costs in this case and finds that petitioner’s request for 

fees and costs, other than the reduction delineated above, is reasonable. Accordingly, 

petitioners are awarded $27,273.10, representing $22,048.35 in attorneys’ fees and 

2 The decision addressing attorneys’ fees and costs in Bhattacharyya is being filed on the same date as 

this decision.
3

$5,224.75 in attorneys’ costs, in the form of a check made payable jointly to petitioners

and Renee J. Gentry, Esq.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the 

clerk of the court is directed to enter judgment herewith.3

IT IS SO ORDERED.

s/Daniel T. Horner

Daniel T. Horner

Special Master

3 Entry of judgment can be expedited by each party’s filing of a notice renouncing the right to seek review. 

Vaccine Rule 11(a).